UK markets open in 1 hour 19 minutes
NIKKEI 225
38,626.39 -6.63 (-0.02%) HANG SENG
18,052.32 -283.00 (-1.54%) CRUDE OIL
82.34 +0.17 (+0.21%) GOLD FUTURES
2,376.50 +7.50 (+0.32%) DOW
39,134.76 +299.90 (+0.77%) Bitcoin GBP
50,979.33 -641.05 (-1.24%)
Lyell Immunopharma, Inc. (LYEL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 531.55M |
| Enterprise value | 60.41M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 7.73k |
| Price/book (mrq) | 0.88 |
| Enterprise value/revenue | 888.34 |
| Enterprise value/EBITDA | 0.35 |
Trading information
Stock price history
| Beta (5Y monthly) | -0.40 |
| 52-week change 3 | -36.20% |
| S&P500 52-week change 3 | 25.87% |
| 52-week high 3 | 3.4100 |
| 52-week low 3 | 1.3200 |
| 50-day moving average 3 | 2.4880 |
| 200-day moving average 3 | 2.0797 |
Share statistics
| Avg vol (3-month) 3 | 781.37k |
| Avg vol (10-day) 3 | 762.46k |
| Shares outstanding 5 | 254.94M |
| Implied shares outstanding 6 | 256.77M |
| Float 8 | 164.22M |
| % held by insiders 1 | 15.40% |
| % held by institutions 1 | 73.25% |
| Shares short (15 May 2024) 4 | 20.1M |
| Short ratio (15 May 2024) 4 | 24.99 |
| Short % of float (15 May 2024) 4 | 11.21% |
| Short % of shares outstanding (15 May 2024) 4 | 7.89% |
| Shares short (prior month 15 Apr 2024) 4 | 18.23M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -1,853,000.00% |
Management effectiveness
| Return on assets (ttm) | -18.93% |
| Return on equity (ttm) | -32.93% |
Income statement
| Revenue (ttm) | 68k |
| Revenue per share (ttm) | 0.00 |
| Quarterly revenue growth (yoy) | -95.40% |
| Gross profit (ttm) | N/A |
| EBITDA | -218.29M |
| Net income avi to common (ttm) | -228.34M |
| Diluted EPS (ttm) | -0.9000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 526.3M |
| Total cash per share (mrq) | 2.06 |
| Total debt (mrq) | 61.83M |
| Total debt/equity (mrq) | 10.25% |
| Current ratio (mrq) | 16.51 |
| Book value per share (mrq) | 2.37 |
Cash flow statement
| Operating cash flow (ttm) | -159.5M |
| Levered free cash flow (ttm) | -84.2M |
© 2024 Yahoo. All rights reserved.